Exact Mass: 461.0869124

Exact Mass Matches: 461.0869124

Found 86 metabolites which its exact mass value is equals to given mass value 461.0869124, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Phosphoglycerol-glutathione

3-Phosphoglycerol-glutathione

C13H24N3O11PS (461.0869124)


   

Azlocillin

(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-{[(2R)-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C20H23N5O6S (461.13689780000004)


Azlocillin is only found in individuals that have used or taken this drug. It is a semisynthetic ampicillin-derived acylureido penicillin.By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, azlocillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that azlocillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

SM-17466

SM-17466

C20H21N4O5S2+ (461.0953316)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

gammaGluCys(IAN)Gly

(glutathion-S-yl)(1H-indol-3-yl)acetonitrile

C20H23N5O6S (461.13689780000004)


A glutathione conjugate that is the S-cyano(indol-3-yl)methyl derivative of glutathione.

   
   

Cyanidin 3-O-(6'-acetyl-arabinoside)

3-{[(2R,3S,4S,5R)-5-[(acetyloxy)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

C22H21O11+ (461.10838160000003)


Cyanidin 3-O-(6-acetyl-arabinoside) is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

KBT 1585 hydrochloride

(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C21H23N3O7S (461.12566480000004)


   

Lactofen

Benzoic acid, 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-, 2-ethoxy-1-methyl-2-oxoethyl ester

C19H15ClF3NO7 (461.04891060000006)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

2,5-Dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate

2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylic acid

C22H21Cl2N3O4 (461.09090460000004)


   

Probenecid Glucuronide

6-[4-(Dipropylsulphamoyl)benzoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C19H27NO10S (461.1355602)


   

Prulifloxacin

6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid

C21H20FN3O6S (461.10567920000005)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   
   

LACTOFEN

Benzoic acid, 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-, 2-ethoxy-1-methyl-2-oxoethyl ester

C19H15ClF3NO7 (461.04891060000006)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

scutellarein 7-O-beta-glucuronamide

scutellarein 7-O-beta-glucuronamide

C21H19NO11 (461.0958064)


   
   

Cyanidin 3-O-(6-acetyl-arabinoside)

3-{[(2R,3S,4S,5R)-5-[(acetyloxy)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1$l^{4}-chromen-1-ylium

C22H21O11 (461.10838160000003)


   

(6-acetyloxy-5-nitro-3-oxospiro[2-benzofuran-1,9-xanthene]-3-yl) acetate

(6-acetyloxy-5-nitro-3-oxospiro[2-benzofuran-1,9-xanthene]-3-yl) acetate

C24H15NO9 (461.07467800000006)


   

dysprosium 2,4-pentanedionate

dysprosium 2,4-pentanedionate

C15H21DyO6 (461.0629896)


   

lenampicillin

lenampicillin

C21H23N3O7S (461.12566480000004)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Vonoprazan Fumarate

Vonoprazan Fumarate (TAK-438)

C21H20FN3O6S (461.10567920000005)


C26170 - Protective Agent > C2459 - Chemoprotective Agent > C2080 - Cytoprotective Agent C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent

   

2-ETHOXY-1-NAPHTHALENECARBOXALDEHYDE

2-ETHOXY-1-NAPHTHALENECARBOXALDEHYDE

C25H20IN (461.064043)


   

3-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-5-(4-methylpiperazin-1-yl)sulfonylthiophene-2-carbonitrile

3-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-5-(4-methylpiperazin-1-yl)sulfonylthiophene-2-carbonitrile

C19H23N7O3S2 (461.1303728)


   

SPA-S 510

Piroxicam cinnamate

C24H19N3O5S (461.1045364000001)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

N-(3-CHLORO-4-FLUOROPHENYL)-7-(3-MORPHOLINOPROPOXY)-6-NITROQUINAZOLIN-4-AMINE

N-(3-CHLORO-4-FLUOROPHENYL)-7-(3-MORPHOLINOPROPOXY)-6-NITROQUINAZOLIN-4-AMINE

C21H21ClFN5O4 (461.12660280000006)


   

Prulifloxacin

Prulifloxacin

C21H20FN3O6S (461.10567920000005)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

N-(Diphenylphosphinyl-α-(p-tosyl)benzyl amine

N-(Diphenylphosphinyl-α-(p-tosyl)benzyl amine

C26H24NO3PS (461.12144440000003)


   

9-(4-Dimethylaminophenyl)-2,6,7-trihydroxyfluorone Sulfate

9-(4-Dimethylaminophenyl)-2,6,7-trihydroxyfluorone Sulfate

C21H19NO9S (461.07804840000006)


   

(-)-Bicuculline methobromide

(-)-Bicuculline methobromide

C21H20BrNO6 (461.04739200000006)


(-)-Bicuculline methobromide (l-Bicuculline methobromide) is a potent GABAA receptor antagonist. (-)-Bicuculline methobromide blocks afterhyperpolarizations (AHPs) mediated by Ca2+-activated K+ channels in various types of neurons[1]. (-)-Bicuculline methobromide (l-Bicuculline methobromide) is a potent GABAA receptor antagonist. (-)-Bicuculline methobromide blocks afterhyperpolarizations (AHPs) mediated by Ca2+-activated K+ channels in various types of neurons[1].

   

2,3,5-TRI-O-ACETYL-8-TRIFLUOROMETHYL ADENOSINE

2,3,5-TRI-O-ACETYL-8-TRIFLUOROMETHYL ADENOSINE

C17H18F3N5O7 (461.1158274)


   

[1,2]benzisothiazolo[2,3,4-lma]benzo[h]quinoxalino[2,3-c]carbazole-11,16-dione 9,9-dioxide

[1,2]benzisothiazolo[2,3,4-lma]benzo[h]quinoxalino[2,3-c]carbazole-11,16-dione 9,9-dioxide

C26H11N3O4S (461.04702460000004)


   

3-Hexyl-1,2-dimethyl-1H-imidazol-3-ium bis[(trifluoromethyl)sulfonyl]azanide

3-Hexyl-1,2-dimethyl-1H-imidazol-3-ium bis[(trifluoromethyl)sulfonyl]azanide

C13H21F6N3O4S2 (461.08776180000007)


   
   

3,6-Bis(acetyloxy)-6-nitrospiro[isobenzofuran-1(3H),9-[9H]xanthen]-3-one

3,6-Bis(acetyloxy)-6-nitrospiro[isobenzofuran-1(3H),9-[9H]xanthen]-3-one

C24H15NO9 (461.07467800000006)


   

MK-5108

MK-5108

C22H21ClFN3O3S (461.0976118000001)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

5-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2:5,3-terpyridine-3-carboxamide

5-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2:5,3-terpyridine-3-carboxamide

C24H20ClN5O3 (461.1254600000001)


   

(2r)-2-(5-Chloro-2-Thienyl)-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Oxoethyl]-2-Oxopyrrolidin-3-Yl}propene-1-Sulfonamide

(2r)-2-(5-Chloro-2-Thienyl)-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Oxoethyl]-2-Oxopyrrolidin-3-Yl}propene-1-Sulfonamide

C18H24ClN3O5S2 (461.08458440000004)


   

4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide

4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide

C21H15ClF3N5O2 (461.08663160000003)


   

5-O-(L-Alpha-Aspartylsulfamoyl)adenosine

5-O-(L-Alpha-Aspartylsulfamoyl)adenosine

C14H19N7O9S (461.0964924)


Asp-AMS, an analogue of aspartyl-adenylate, is an aspartyl-tRNA synthetase inhibitor and also a strong competitive inhibitor of the mitochondrial enzyme. Asp-AMS, an analogue of aspartyl-adenylate, is an aspartyl-tRNA synthetase inhibitor and also a strong competitive inhibitor of the mitochondrial enzyme.

   

2,5-Dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate

2,5-Dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate

C22H21Cl2N3O4 (461.09090460000004)


   
   

[3-(2-Chloro-6-ethoxy-3-quinolinyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-thiophen-2-ylmethanone

[3-(2-Chloro-6-ethoxy-3-quinolinyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-thiophen-2-ylmethanone

C25H20ClN3O2S (461.09646900000007)


   

(1R)-2-[(Cyanomethyl)amino]-1-({[2-(difluoromethoxy)benzyl]sulfonyl}methyl)-2-oxoethyl morpholine-4-carboxylate

(1R)-2-[(Cyanomethyl)amino]-1-({[2-(difluoromethoxy)benzyl]sulfonyl}methyl)-2-oxoethyl morpholine-4-carboxylate

C18H21F2N3O7S (461.106822)


   

2-({[2,3,5,6-Tetrafluoro-3-(Trifluoromethoxy)biphenyl-4-Yl]amino}carbonyl)cyclopenta-1,3-Diene-1-Carboxylic Acid

2-({[2,3,5,6-Tetrafluoro-3-(Trifluoromethoxy)biphenyl-4-Yl]amino}carbonyl)cyclopenta-1,3-Diene-1-Carboxylic Acid

C20H10F7NO4 (461.0498024000001)


   
   

1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside 3-phosphate(2-)

1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside 3-phosphate(2-)

C14H24NO14P-2 (461.0934374)


   

Isoscoparin-7-olate

Isoscoparin-7-olate

C22H21O11- (461.10838160000003)


The 7-oxoanion of isoscoparin.

   

N-monoacetylchitobiose-6-phosphate(1-)

N-monoacetylchitobiose-6-phosphate(1-)

C14H26N2O13P- (461.1172456)


   

Luteolin 7-O-beta-D-Glucuronide

Luteolin 7-O-beta-D-Glucuronide

C21H17O12- (461.0719982)


   

alpha-Ketoglutaryl-diaminobutyryl-citryl-ethanolamine

alpha-Ketoglutaryl-diaminobutyryl-citryl-ethanolamine

C17H23N3O12-2 (461.1281678)


   

Diaminobutyryl-citryl-ethanolamino-alpha-ketoglutarate

Diaminobutyryl-citryl-ethanolamino-alpha-ketoglutarate

C17H23N3O12-2 (461.1281678)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (2S)-2,4-diamino-4-oxobutanoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (2S)-2,4-diamino-4-oxobutanoate

C14H20N7O9P (461.10600800000003)


   
   
   
   

3-[[4-(2,6-Difluoro-4-methoxyphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]aniline

3-[[4-(2,6-Difluoro-4-methoxyphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]aniline

C18H21F2N3O5S2 (461.089064)


   

Cefamandole(1-)

Cefamandole(1-)

C18H17N6O5S2- (461.07018120000004)


A cephalosporin carboxylate anion having (R)-mandelamido and N-methylthiotetrazole side-groups.

   

3-L-asparaginyl-AMP

3-L-asparaginyl-AMP

C14H20N7O9P (461.10600800000003)


An L-asparaginyl derivative that is the ester obtained by formal condensation of the carboxy group of L-asparagine with the 3-hydroxy group of AMP.

   

3-chloro-4-[4-(4-fluorophenyl)sulfonyl-1-piperazinyl]-N,N-dimethylbenzenesulfonamide

3-chloro-4-[4-(4-fluorophenyl)sulfonyl-1-piperazinyl]-N,N-dimethylbenzenesulfonamide

C18H21ClFN3O4S2 (461.06459880000006)


   

1-[4-Chloro-3-[(2-methoxyphenyl)sulfamoyl]phenyl]-3-(2-methoxyphenyl)urea

1-[4-Chloro-3-[(2-methoxyphenyl)sulfamoyl]phenyl]-3-(2-methoxyphenyl)urea

C21H20ClN3O5S (461.0812140000001)


   

N-[4-(4-methoxyphenyl)-2-thiazolyl]-2-[(4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]acetamide

N-[4-(4-methoxyphenyl)-2-thiazolyl]-2-[(4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]acetamide

C23H19N5O2S2 (461.0980114)


   

2-[(5Z)-5-[(3-ethoxy-4-hydroxy-5-nitrophenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(2-fluorophenyl)acetamide

2-[(5Z)-5-[(3-ethoxy-4-hydroxy-5-nitrophenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(2-fluorophenyl)acetamide

C20H16FN3O7S (461.0692958)


   

4-methoxy-N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]benzamide

4-methoxy-N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]benzamide

C24H19N3O5S (461.1045364000001)


   

3-[(5Z)-5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(phenylsulfonyl)propanehydrazide

3-[(5Z)-5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(phenylsulfonyl)propanehydrazide

C20H19N3O4S3 (461.0537654000001)


   

2-[4-(2-Thiophen-2-ylquinazolin-4-yl)piperazin-1-yl]sulfonylbenzonitrile

2-[4-(2-Thiophen-2-ylquinazolin-4-yl)piperazin-1-yl]sulfonylbenzonitrile

C23H19N5O2S2 (461.0980114)


   

2-(2-Chloro-6-fluoro-phenyl)-3-(4,6-diphenylpyrimidin-2-yl)thiazolidin-4-one

2-(2-Chloro-6-fluoro-phenyl)-3-(4,6-diphenylpyrimidin-2-yl)thiazolidin-4-one

C25H17ClFN3OS (461.07648340000003)


   

1-(4-Chlorophenyl)-6-[(4-methylphenyl)methyl]-3-[oxo(thiophen-2-yl)methyl]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-7-one

1-(4-Chlorophenyl)-6-[(4-methylphenyl)methyl]-3-[oxo(thiophen-2-yl)methyl]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-7-one

C23H16ClN5O2S (461.07131860000004)


   

2-O-acetylcrinamabine Trifluoroacetic acid

2-O-acetylcrinamabine Trifluoroacetic acid

C20H22F3NO8 (461.1297448)


A natural product found in Crinum asiaticum var. sinicum.

   

2-methylthio-N(6)-dimethylallyladenine 5-monophosphate

2-methylthio-N(6)-dimethylallyladenine 5-monophosphate

C16H24N5O7PS (461.11340040000005)


   

(2S,5S,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-1-oxo-2-[[oxo-(2-oxo-1-imidazolidinyl)methyl]amino]-2-phenylethyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(2S,5S,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-1-oxo-2-[[oxo-(2-oxo-1-imidazolidinyl)methyl]amino]-2-phenylethyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C20H23N5O6S (461.13689780000004)


   

4-methoxyphenyl 3-O-(beta-D-glucopyranosyluronate)-beta-D-galactopyranoside

4-methoxyphenyl 3-O-(beta-D-glucopyranosyluronate)-beta-D-galactopyranoside

C19H25O13- (461.12951)


   

(2S,3S,4S,5R)-6-[3-acetamido-2-hydroxy-5-(4-methylbenzoyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-6-[3-acetamido-2-hydroxy-5-(4-methylbenzoyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H23NO10 (461.1321898)


   

(5R)-5-(3,5-dichloro-4-fluorophenyl)-3-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-5-(trifluoromethyl)-4H-1,2-oxazole

(5R)-5-(3,5-dichloro-4-fluorophenyl)-3-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-5-(trifluoromethyl)-4H-1,2-oxazole

C19H14BCl2F4NO3 (461.0379872000001)


   

N-(1,3-benzothiazol-2-yl)-4-methylsulfonyl-3-nitro-N-[[(2R)-oxolan-2-yl]methyl]benzamide

N-(1,3-benzothiazol-2-yl)-4-methylsulfonyl-3-nitro-N-[[(2R)-oxolan-2-yl]methyl]benzamide

C20H19N3O6S2 (461.07152340000005)


   

Azlocillin

Azlocillin

C20H23N5O6S (461.13689780000004)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum A semisynthetic penicillin antibiotic used in treating infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

luteolin 7-O-beta-D-glucosiduronate

luteolin 7-O-beta-D-glucosiduronate

C21H17O12 (461.0719982)


A carbohydrate acid derivative anion that is the conjugate base of luteolin 7-O-beta-D-glucosiduronic acid, arising from deprotonation of the carboxy group; major species at pH 7.3.

   

Cyanidin 3-O-(6-acetyl-arabinoside)

Cyanidin 3-O-(6-acetyl-arabinoside)

C22H21O11+ (461.10838160000003)


   

Phosphoglycerol-glutathione

Phosphoglycerol-glutathione

C13H24N3O11PS (461.0869124)


   

B-Raf IN 2

B-Raf IN 2

C20H17F2N5O4S (461.0969266000001)


B-Raf IN 2 is a potent and selective BRAF inhibitor extracted from patent WO2021116055A1, compound Ia. B-Raf IN 2 can be used for the research of cancer[1].

   

FAUC 365

FAUC 365

C23H25Cl2N3OS (461.10953)


FAUC 365 is a highly dopamine D3 receptor-selective antagonist with Ki values of 0.5 nM, 340, 2600, and 3600 nM at D3, D4.4, D2short, and D2Long receptors, respectively. FAUC 365 can be used for the research of schizophrenia, and Parkinson's disease[1][2].